Valuation • Minimed Group
MMED
Minimed Group, Inc. is a healthcare technology company dedicated to improving the lives of individuals with diabetes through the design, manufacture, and sale of advanced medical devices. The company's primary focus is on insulin delivery systems, including wearable insulin pumps and related accessories, which are designed to provide more precise and user-friendly management of blood glucose levels. Operating within the Health Care Equipment industry, Minimed Group emphasizes the integration of hardware and software to create seamless diabetes care ecosystems. Their products target both Type 1 and Type 2 diabetes patients, focusing on enhancing clinical outcomes while reducing the daily burden of disease management. The company's technology often incorporates data connectivity and automated features, aligning with the industry trend toward 'smart' medical devices and automated insulin delivery (AID) systems. Minimed Group's strategic initiatives involve significant investment in research and development to maintain a pipeline of next-generation devices. By leveraging data analytics and patient-centric design, the company aims to capture market share in the global diabetes care sector, competing with other major medical device manufacturers by offering specialized, high-performance insulin delivery platforms.
—
P/B
Book value of equity per share effectively indicates a firm's net asset value (total assets - total liabilities) on a per-share basis. References: Below 1: the company is trading below its equity. Equal to 1: the company is trading at the exact value of its equity. Above 1: The company is trading above its equity.
—
P/S
Shows how much the market values every dollar of the company's sales.
—
P/EBITDA
Shows how much the market values every dollar of the company's EBITDA.
—
P/OCF
The price-to-cash flow (P/CF) ratio is a stock valuation indicator or multiple that measures the value of a stock's price relative to its operating cash flow per share. The ratio uses operating cash flow (OCF), which adds back non-cash expenses such as depreciation and amortization to net income. P/CF is especially useful for valuing stocks that have positive cash flow but are not profitable because of large non-cash charges.
—
P/FCF
The price-to-free cash flow (P/FCF) ratio is a stock valuation indicator or multiple that measures the value of a stock's price relative to its free cash flow per share. This metric is very similar to the valuation metric of price to cash flow but is considered a more exact measure because it uses free cash flow, which subtracts capital expenditures (CAPEX) from a company's total operating cash flow, thereby reflecting the actual cash flow available to fund non-asset-related growth.
—
P/E
The price-to-earnings ratio is the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS) and is used by investors and analysts to determine the relative value of a company's shares in an apples-to-apples comparison.
13,7
BVPS
Book value per share (BVPS) takes the ratio of a firm's common equity divided by its number of shares outstanding.
—
EPS
Earnings per share (EPS) is calculated as a company's profit divided by the outstanding shares of its common stock. The resulting number serves as an indicator of a company's profitability. EPS indicates how much money a company makes for each share of its stock and is a widely used metric for estimating corporate value.
Premium
- Unrestricted access
- Unlimited data history
- Analysis videos
- Quarterly highlights
- Customizable financials table
- Ranking
- Discussions
...and much more!